Crossmark

Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians’ current practices

Crossref DOI link: https://doi.org/10.1186/s13023-018-0978-0

Published Online: 2019-01-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Yuskiv, Nataliya

Potter, Beth K.

Stockler, Sylvia

Ueda, Keiko

Giezen, Alette

Cheng, Barbara

Langley, Erica

Ratko, Suzanne

Austin, Valerie

Chapman, Maggie

Chakraborty, Pranesh

Collet, Jean Paul

Pender, Amy
Funding

Funding for this research was provided by:

IRSC-CIHR (119195)
License Information

Text and Data Mining valid from 2019-01-08
More Information

Article History

Received: 9 July 2018

Accepted: 11 December 2018

First Online: 8 January 2019

Ethics approval and consent to participate

: The survey study protocol was submitted to Research Ethics Board of the University of British Columbia and received initial REB approval in August 8, 2015 (H15–01291).

: Not applicable.

: Dr. Stockler received research funding for clinical trials related to PAH deficiency (PKU015, PKU 016, BioMarin). The other authors declare no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.